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Abstract
Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in
infancy by an acute encephalopathic crisis and often results in permanent motor handicap. Biochemical hallmarks of this
disease are elevated levels of glutarate and 3-hydroxyglutarate in blood and urine. The neuropathology of this disease is still
poorly understood, as low lysine diet and carnitine supplementation do not always prevent brain damage, even in early-
treated patients. We used a 3D in vitro model of rat organotypic brain cell cultures in aggregates to mimic glutaric aciduria
type I by repeated administration of 1 mM glutarate or 3-hydroxyglutarate at two time points representing different
developmental stages. Both metabolites were deleterious for the developing brain cells, with 3-hydroxyglutarate being the
most toxic metabolite in our model. Astrocytes were the cells most strongly affected by metabolite exposure. In culture
medium, we observed an up to 11-fold increase of ammonium in the culture medium with a concomitant decrease of
glutamine. We further observed an increase in lactate and a concomitant decrease in glucose. Exposure to 3-
hydroxyglutarate led to a significantly increased cell death rate. Thus, we propose a three step model for brain damage in
glutaric aciduria type I: (i) 3-OHGA causes the death of astrocytes, (ii) deficiency of the astrocytic enzyme glutamine
synthetase leads to intracerebral ammonium accumulation, and (iii) high ammonium triggers secondary death of other
brain cells. These unexpected findings need to be further investigated and verified in vivo. They suggest that intracerebral
ammonium accumulation might be an important target for the development of more effective treatment strategies to
prevent brain damage in patients with glutaric aciduria type I.
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Introduction
Glutaric aciduria type I (GA-I; MIM #231670) is an autosomal
recessive disorder caused by mutations in the mitochondrial
enzyme glutaryl-CoA dehydrogenase (GCDH; EC 1.3.99.7; MIM
*608801) [1]. Deficient GCDH activity affects tryptophan, lysine
and hydroxylysine catabolism and results in the accumulation of
glutaric acid (GA), 3-hydroxyglutaric acid (3-OHGA) and to
a lesser extent glutaconic acid and glutaryl carnitine in body fluids
and tissues [2,3,4]. GA-I belongs to a disease group in which in
spite of generalized metabolic derangement, the symptoms are
almost exclusively neurologic – the so-called ‘‘cerebral organic
acidurias’’ [5]. After a pre-symptomatic period in which macro-
cephaly and/or subtle neurological signs can be noticed, most
children with GA-I present with an acute encephalopathic crisis
that usually occurs between the 6th and 18th month of life following
an intercurrent infection or immunization. During this crisis,
previously acquired motor skills are lost and permanent motor
handicap remains. Neuroimaging shows bilateral destruction of
caudate and putamen. A minority of patients experiences the
insidious onset of this disease with delayed motor development and
progressive dystonic cerebral palsy [1,6,7]. Early diagnosis and
treatment allows preventing brain damage at least in part. Low
lysine diet in combination with carnitine and anti-catabolic
emergency treatment is the standard management in pre-
symptomatic infants. However, up to one third of pre-symptom-
atically diagnosed patients (e.g. via newborn screening) encounter
striatal injury or show fine motor and speech deficits [8,9,10,11].
Nearly three decades of scientific research on the origin of
neurological damage in organic acidurias have only partially
uncovered the mechanisms of neurotoxicity in these disorders. The
‘‘toxic metabolite’’ and ‘‘trapping’’ hypotheses suggest that the
production and accumulation of putative toxic metabolites in
brain are involved in the pathomechanisms of organic acidurias.
Following the ‘‘toxic metabolite’’ theory, GA and 3-OHGA are
supposed to be putative brain cell toxins when produced and/or
accumulated in the central nervous system of GA-I patients. These
theories have directed the research towards neurotoxicity studies
of the main metabolites accumulating in these diseases (reviewed
in [9]). Three mechanisms have been suggested to be involved in
the pathogenesis of this disease: i) excitotoxicity, ii) impairment of
cerebral energy metabolism and iii) induction of oxidative stress
[9].
A Gcdh2/2 mouse model was generated that showed a bio-
chemical phenotype similar to GA-I patients. Pathologically, these
mice have a diffuse spongiform myelinopathy similar to that in
human patients [12]. However, they do not present typical
encephalopathic crises unless under high protein or high lysine
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diet. High protein diet is rapidly lethal, while 4 week-old Gcdh2/2
mice under high lysine develop vasogenic edema, blood-brain
barrier breakdown, neuronal loss, hemorrhage, paralysis and
seizures, and die after 3–12 days. In contrast, most 8-week-old
Gcdh2/2 mice survive on high lysine diet, but develop white matter
lesions, reactive astrocytes and neuronal loss [13]. Despite existing
evidence for the role of GA and 3-OHGA in the neurotoxicity of
GA-I, the neuropathogenesis of this disease still remains poorly
understood.
We developed an in vitro model for the study of neurotoxicity in
GA-I by exposing 3D organotypic rat brain cell cultures in
aggregates to GA and 3-OHGA. This model mimics the
production and accumulation of these metabolites during a met-
abolic crisis. We analyzed the effect of GA and 3-OHGA on brain
cells in immature and more developed stages of the cultures. Cell
morphology, cell death, and the metabolic profile in the culture
medium have been studied.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance to the Ethical
Principles and Guidelines for Scientific Experiments on Animals of
the Swiss Academy for Medical Sciences. The protocol was
approved by the Ethics Committee for Animal Experimentation
(Service de la consommation et des affaires ve´te´rinaires, Epalinges,
Switzerland; No. 1172.5). Sufficient amount of food and water for
transportation and period before sacrificing of the rats was added
by the commercial provider. All animals were sacrificed 48 hours
after commercial delivery by decapitation with the use of
a guillotine to avoid animal suffering.
Rat 3D Organotypic Brain Cell Cultures in Aggregates
Pregnant Sprague-Dawley rats (Harlan; Netherlands) were
sacrificed on day 15 of gestation. Fetal whole brains were
extracted, pooled and mechanically dissociated. 3.66107 cells
were grown in 8 ml of a serum-free, chemically-defined medium
with 25 mM glucose and maintained under constant gyratory
agitation at 37uC, in an atmosphere of 10% CO2 and 90%
humidified air to form reaggregated 3D primary brain cell cultures
as previously described [14,15]. Media were replenished every
three days from day-in-vitro (DIV) 5, by exchanging 5 ml of
medium per culture. On the day of harvest aggregate pellets were
washed three times with ice-cold PBS and either embedded for
histology in cryoform (Tissue-Tek O.C.T. Compound, Sakura
Finetek, Netherlands) and frozen in liquid nitrogen-cooled 2-
methylbutane (Sigma-Aldrich, Germany); or directly frozen in
liquid nitrogen and kept at 280uC until analysis.
Treatment Protocol
Cultures were treated with 1 mM glutaric acid (GA; Sigma-
Aldrich, Germany) or 3-hydroxyglutaric acid (3-OHGA; Ernesto
Brunet-Romero, Madrid, Spain) buffered in 25 mM HEPES with
pH adjusted to 7.5. Cultures were exposed to one of the two
metabolites 6 times every 12 hours at two different developmental
stages starting from DIV 5 in protocol A or from DIV 11 in
protocol B (Figure 1). Aggregates were harvested 5 hours after the
last treatment at DIV 8 in protocol A and at DIV 14 in protocol B.
Immunohistochemistry
Immunohistochemical staining was carried out on 16 mm
aggregate cryosections using antibodies against different markers
of brain cell types: phosphorylated medium weight neurofilament
(p-NFM; clone NN18, Sigma-Aldrich, USA) for neurons [16], glial
fibrillary acidic protein (GFAP; Millipore, USA) for astrocytes,
galactocerebroside (GalC; Millipore, USA) on DIV 8 and myelin
basic protein (MBP; Santa Cruz Biotechnology, USA) on DIV 14
for oligodendrocytes, and peroxidase-labeled isolectin B4 (Sigma-
Aldrich, USA) on DIV 8 for microglia. Briefly, sections were fixed
for 1 h in 4% paraformaldehyde in PBS at room temperature.
Endogenous peroxidase activity was quenched with 1.5% H2O2 in
PBS (Sigma-Aldrich, Germany) and non-specific antibody binding
sites were blocked with 1% bovine serum albumin (Sigma-Aldrich,
Germany) in PBS for 1 h. Primary antibodies diluted 1:100 in 1%
bovine serum albumin in PBS where applied to sections and
further detected with anti-mouse or anti-rabbit IgG coupled to
horseradish peroxidase (HRP, Bio-Rad Laboratories, USA).
Staining was processed using the AEC Substrate Set for BDTM
ELISPOT according to the manufacturer’s protocol (BD Bios-
ciences, USA). For negative controls, the primary antibodies were
omitted resulting in no staining. The stained sections were
mounted under FluorSaveTM Reagent (Calbiochem, USA),
observed and digitized using an Olympus BX50 microscope
equipped with a UC30 digital camera (Olympus, Japan).
Immunofluorescence
Detection of cleaved caspase-3 in aggregates was performed
with the Tyramide Signal Amplification Kit (Life Technologies,
USA). Aggregate cryosections (16 mm) were subjected to the same
procedure as described above for immunohistochemistry. Non-
specific antibody binding sites were blocked for 1 h at room
temperature with the blocking buffer of the kit. The primary
antibody against the large fragment (17/19 kDa) of activated
caspase-3 (Cell Signaling Technology, USA), diluted 1:1000 in
blocking buffer, was applied to sections overnight at 4uC. After
washing, sections were incubated with a HRP anti-rabbit IgG
secondary antibody (provided by the kit) for 1 h. Peroxidase
staining was performed using Alexa FluorH 555-labeled tyramide
diluted 1:200 in amplification buffer (provided by the kit) and
applied to sections for 10 min. Negative controls were processed
the same but omitting the primary antibody resulting in no
staining. Sections were mounted under FluorSaveTM reagent. The
sections were observed and photographed with an Olympus BX50
microscope equipped with a UC30 digital camera.
In situ Cell Death Detection
To detect typical features of apoptosis (fragmented nuclei,
apoptotic bodies), nuclear DNA was stained using the blue
fluorescent 4’,6-diamidino-2-phenylindole (DAPI, Invitrogen,
USA). Aggregate cryosections (16 mm) were incubated with DAPI
for 10 min at room temperature. In situ detection of cell death was
performed using terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick end labeling (TUNEL) on 16 mm cryosec-
tions of aggregates. TUNEL staining was performed according to
supplier recommendations using the In Situ Cell Death Detection
Kit with Fluorescein (Roche Applied Science, Switzerland)
resulting in green fluorescence in dying cells.
Western Blot Analysis
Aggregates were homogenized in 150 mM sodium chloride,
50 mM Tris-HCl, pH 8, 1% NP-40 (Sigma-Aldrich, Germany)
and Protease Inhibitor Cocktail - Complete Mini (Roche Applied
Science, Switzerland) and sonicated for 5 seconds. Lysates were
cleared by centrifugation at 129000 rpm for 30 min at 4˚C. After
dilution, protein content was measured by bicinchoninic acid assay
(Thermo Scientific, USA) and diluted with NuPAGEH LDS
Sample Buffer (Life Technologies, USA) to a final concentration of
1.2 mg/ml. Samples were heated at 70uC for 10 min and resolved
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on NuPAGEH 4–12% Bis–Tris Gel (for p-NFM) or NuPAGEH
12% Bis–Tris Gel (for GFAP, MBP, actin and caspase-3) using
NuPAGEH MOPS SDS Running Buffer (Life Technologies, USA)
at a constant voltage (200 V, 60 min). Proteins were transferred
onto Immobilon-FL PVDF, 0.45 mm membranes (Millipore,
USA). Membranes were blocked with 5% non-fat dry milk in
TBS-Tween (20 mM Trizma base, 137 mM NaCl, 0.05% Tween,
pH 7.6) for 1 h at room temperature. After blocking, the
membranes were incubated overnight with different primary
antibodies against GFAP, MBP, p-NFM, Actin (I-19) (Santa Cruz
Biotechnology, USA) or full-length (35 kDa) and large fragment
(17/19 kDa) of caspase-3 (Cell Signaling Technology, USA)
diluted 1:1000 in 3% dry milk and TBS-Tween. The membranes
were probed with HRP-conjugated goat anti-mouse IgG or goat
anti-rabbit IgG (1:3000; Vector laboratories, USA) and developed
by chemiluminescence (ECL Western Blotting Detection Re-
agents; GE Healthcare, France). Blots were stripped (ReBlot Plus
Mild Antibody Stripping Solution; Millipore, USA) and re-probed
with antibody against actin as the loading control. Images were
taken with a Luminescent Image Analyzer LAS-4000 (Fujifilm;
Life Science) and quantified with the public Java-based image
processing program ImageJ (National Institutes of Health). Data
were acquired in arbitrary densitometric units and transformed to
percentages of the densitometric levels obtained from scans of
control samples visualized on the same blots.
Measure of Basic Metabolites and Amino Acids in the
Culture Media
Ammonium was measured on an Integra automatic analyzer
(Roche); glucose, lactate and lactate dehydrogenase (LDH) were
measured on a Modular automatic analyzer (Roche); free amino
acids were analyzed on a Beckman 6300 amino acid analyzer; as
described previously [17]; lactate and pyruvate for measurement
of the lactate/pyruvate ratio were measured by GC/MS (HP
6890 N, Agilent Technologies).
Expression of GCDH in Brain Cells
Non-radioactive in situ hybridization for Gcdh mRNA, making
use of digoxygenin-labeled riboprobes transcribed from Gcdh
cDNA, was performed on adult rat brain cryosections (16 mm), as
described [14]. Sections were then co-labeled by immunohisto-
chemistry with specific antibodies for neurons (neuronal nuclei
protein; NeuN; Millipore, USA), astrocytes (GFAP) and oligoden-
drocytes (MBP).
Statistics
All data points are expressed as mean 6 standard deviation
(SD). Statistical difference was determined with Student’s t-test.
Results
GA and 3-OHGA Exposure Altered the Morphology of
Developing Brain Cells
Neurons. Immunohistochemical staining for p-NFM on
cryosections from cultures exposed to GA and 3-OHGA did not
show any eminent effects on the expression and distribution of p-
NFM in both treatment protocols. We observed normal axonal
elongation and no aberrant accumulation of this protein in the
cellular body. However, we could see a substantial overall tissue
damage in the aggregates exposed to 3-OHGA under protocol A
(DIV 8) and even more remarkably under protocol B (DIV 14)
(Figure 2, left panel). Quantitative analysis of p-NFM
expression by western blotting did not reveal any significant
changes in the treated cultures compared to control (Figure 2,
right panel).
Astrocytes. GFAP immunohistochemical staining revealed
a decrease in astrocytic fiber density in cultures exposed to 3-
OHGA and to a lesser extent also in those treated with GA, for
both treatment protocols (Figure 3, left panel). Interestingly, 3-
OHGA exposure led to appearance of proximal fiber swelling in
surviving astrocytes in immature cultures (DIV 8) as indicated by
arrows in Figure 3. Similarly to the observations for the p-NFM
signal in neurons, we could again see severe tissue damage in 3-
OHGA-exposed aggregates in protocol B (DIV 14), suggesting
massive cell death. GFAP expression in surviving astrocytes was
not significantly altered as shown by western blot analyses
(Figure 3, right panel).
Figure 1. Treatment protocols. Cultures of aggregates were exposed to 1 mM GA and 3-OHGA at two time points representing different
developmental stages of brain cell maturation (Protocols A and B). Metabolites were added 6 times every 12 hours (indicated by arrows) starting on
DIV 5 in protocol A and on DIV 11 in protocol B (treatment days are indicated by black boxes) 12 hours after the change of the medium. Aggregates
were harvested 5 hours after the last treatment at DIV 8 in protocol A and at DIV 14 in protocol B.
doi:10.1371/journal.pone.0053735.g001
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Oligodendrocytes. 3-OHGA-exposure, and to a lesser ex-
tent GA-exposure, resulted in a substantial decrease of MBP
staining under protocol B (DIV 14) (Figure 4, left panel).
Western blot analysis confirmed decreased MBP expression under
the same conditions (Figure 4, right panel). We could not see
any effect for MBP staining in protocol A since the expression of
MBP protein is very low in the immature developmental stages
(data not shown). In order to discriminate whether the observed
signal loss is a result of oligodendrocytic death or altered
differentiation and/or myelination, we performed immunohisto-
chemical staining for GalC, one of the earliest markers of
oligodendrocytes. Only slight reduction of GalC signal was
observed in the cultures treated with 3-OHGA on DIV 8
(Figure 4, left panel) and no difference was seen with any of
the two metabolites on DIV 14 (data not shown).
Microglia. The presence of microglia was tested by immu-
nostaining for isolectin B4 at DIV 8. No interesting changes were
observed (data not shown).
Biochemical Parameters in Culture Media after Exposure
to GA and 3-OHGA
Glucose and Lactate. As compared to controls, GA and 3-
OHGA exposure caused a significant decrease in the glucose levels
under protocol B (DIV 14), while the glucose levels of immature
cultures (protocol A, DIV 8) were not significantly changed
(Figure 5A). In parallel, a significant increase in lactate levels was
observed in the medium of treated DIV 14 cultures. Lactate
release into medium remained unchanged in immature DIV 8
cultures (Figure 5B). The lactate/pyruvate ratio was increased in
the medium of DIV 14 3-OHGA-exposed cultures (55.4 under
1 mM 3-OHGA versus 26.2 in controls; mean of duplicates for
each condition).
Ammonium and Glutamine. A massive increase in ammo-
nium concentrations was measured in the culture media after
exposure to 3-OHGA and GA under both protocols (DIV 8 and
14) (Figure 5C). Among amino acids measured in the culture
medium, a significant decrease was observed on glutamine levels
in all cultures exposed to GA and 3-OHGA under both protocols
(Figure 5D).
Increased Cell Death in Developing Brain Cells After
Exposure to GA and 3-OHGA
Lactate dehydrogenase (LDH) was measured in culture medium
and was significantly increased after 3-OHGA- and GA-exposure
in both protocols (DIV 8 and DIV 14) (Figure 6C). This
observation indicated an increase of cell death in these cultures.
To evaluate cell death, we performed TUNEL, DAPI and
activated caspase-3 immunofluorescence staining. DAPI staining
did not show an increased appearance of nuclear fragmentation
and apoptotic bodies in cultures under both protocols, as
compared to control (data not shown). Immunofluorescence
staining for cleaved caspase-3 revealed no difference in the
Figure 2. Effects of GA and 3-OHGA on neurons. (Left panel) Immunohistochemical staining for phosphorylated medium weight neurofilament
(p-NFM) on cryosections of cultures derived from protocol A (DIV 8) and protocol B (DIV 14). Scale bar: 100 mm. (Right panel) Representative western
blots with data quantification of whole-cell lysates for p-NFM for protocol A (DIV 8, above) and protocol B (DIV 14, below). Actin was used as a loading
control. The quantifications of p-NFM are expressed as percentage of respective controls. The values represent the mean 6 SD from 3 replicates
taken from 2 independent experiments.
doi:10.1371/journal.pone.0053735.g002
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number of positively stained cells (e.g. apoptotic) in cultures
exposed to GA and 3-OHGA in both treatment protocols as
compared to control (Figure 6A, left panel). Accordingly, no
significant changes were observed on activated caspase-3 level
assessed by western blotting under both metabolites treatment at
DIV 14. In protocol A, a tendency of activated caspase-3 to
decrease in GA- and 3-OHGA-exposed aggregates was observed,
however, the changes were not significant (Figure 6A, right
panel). Interestingly, TUNEL labeling (green staining) showed an
important signal increase for cultures treated with 3-OHGA on
DIV 8, which only partially co-localized (yellow staining) with
cleaved caspase-3-labeled apoptotic cells (red signal) (Figure 6B).
This suggests an induction of non-apoptotic cell death in
developing brain cells under 3-OHGA exposure. TUNEL signal
in 3-OHGA exposed cultures was homogenously distributed over
the entire aggregate, suggesting that 3-OHGA diffused well from
the medium into the whole aggregate (Figure 6B, 106magnifica-
tions).
GCDH Expression in Adult Rat Brain
Gcdh mRNA was found expressed in the whole rat brain,
exclusively in neurons (Figure 7). No Gcdh mRNA was detectable
in astrocytes or in oligodendrocytes.
Discussion
We used 3D organotypic brain cell cultures in aggregates to
explore, in vitro, the effects of the two main metabolites (GA and 3-
OHGA) accumulated in body fluids of subjects affected by GA-I.
Our in vitro model is particularly suitable for studying neurotoxicity
because the aggregates contain all types of brain cells with their
spontaneous connections between each other. In addition, this
model reproduces early phases of brain development and has
proven to be optimal to study differential effects of metabolic
derangements (such as hyperammonemia) in developing brain
compared to adult brain tissue [14,15,16,18]. This is particularly
important when studying a disorder in which the most dramatic
brain damage occurs in early childhood.
In our study, we could confirm that both GA and 3-OHGA
were deleterious for brain cells during development, but 3-OHGA
turned out to be the most toxic metabolite. The most striking effect
of 3-OHGA on the aggregates was massive tissue destruction with
wide areas of cell death, which was evident on DIV 14 (Figures 2
and 3). In both developmental stages (DIV 8 and 14) astrocytes
appeared more susceptible to GA and 3-OHGA toxicity than
neurons and oligodendrocytes, showing important morphological
changes (decrease in fiber density and swelling of proximal fibers).
These results are in line with the findings in the Gcdh2/2 mouse
which under high lysine diet show reactive astrocytes [13].
Surprisingly, neurons did not show any significant alteration in our
model. This might be due to their origin from wild type animals,
Figure 3. Effects of GA and 3-OHGA on astrocytes. (Left panel) Immunohistochemical staining for glial fibrillary acidic protein (GFAP) on
cryosections of cultures derived from protocol A (DIV 8) and protocol B (DIV 14). Swollen proximal fibers are indicated by black arrows. Scale bar:
100 mm. (Right panel) Representative western blots with data quantification of whole-cell lysates for GFAP for protocol A (DIV 8, above) and protocol
B (DIV 14, below). Actin was used as a loading control. The quantifications of GFAP levels are expressed as percentage of respective controls. The
values represent the mean 6 SD from 3 replicates taken from 2 independent experiments.
doi:10.1371/journal.pone.0053735.g003
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thus expressing Gcdh, or a too short observation time if they die
secondarily to astrocytes and consecutive ammonium accumula-
tion (see below). The observation of primary astrocytic reactivity
and secondary neuronal death has already been described in a rat
model using intracerebroventricular injection of GA [19].
Oligodendrocytes reacted differently. While under GA and 3-
OHGA exposures GalC labeling was not significantly altered on
both DIV 8 and DIV 14, MBP expression on DIV 14 was
decreased. These results suggest delayed or altered differentiation
of oligodendrocytes rather than their death. Delayed myelination
and supratentorial white matter lesions have been described in
GA-I patients with and without preceding encephalophatic crises
[6] and in the Gcdh2/2 mouse under high lysine diet [13].
Massive cell death in cultures exposed to both metabolites was
also confirmed by LDH increase and by striking increase of in situ
cell death detection by TUNEL assay. As treated cultures did not
show an increase of activated caspase-3, we conclude that the GA-
and 3-OHGA-induced cell death was mainly non-apoptotic. As
astrocytes appeared the most affected cells (see above), and as 3-
OHGA (and GA) exposure caused a massive elevation of
ammonium in parallel with a decrease of glutamine in the culture
medium (see above), this study suggests that astrocytes exposed to
3-OHGA (and GA) are the primary cells to die. Astrocyte
susceptibility to 3-OHGA and GA toxicity may be due to the
absence of Gcdh expression in these cells (see Figure 7).
Unexpectedly, a striking increase of ammonium was observed in
the medium of cultures exposed to GA and 3-OHGA. The
decreasing ammonium level of control cultures between DIV 8
and DIV 14 can be explained by the maturation of astrocytes,
which increases their capacity to metabolize ammonium. Hyper-
ammonemia can be seen occasionally in patients with organic
acidurias during metabolic decompensation, but is usually
moderate and transitory, and was so far thought to be of hepatic
origin. In contrast, the observed ammonium accumulation in our
in vitro model indicates that significant amounts of ammonium are
produced by brain cells under the action of GA and 3-OHGA,
suggesting a central liberation of ammonium in GA-I. Following
the guidelines for GA-I, ammonium is not routinely determined
during an acute illness [10,11], but could be worth to be measured
in CSF.
Ammonium is known to be toxic for brain cells causing reduced
axonal elongation [16] as well as neuronal and oligodendrocytic
cell death [15,18], which correlates with the brain atrophy and
white matter changes observed in patients with primary hyper-
ammonemias [20]. Its detection in brain cell cultures challenged
with GA and 3-OHGA immediately raises the question of
a potential role for ammonium in brain damage occurring in
GA-I patients. As urea cycle is not active in central nervous
system, ammonium produced during amino acid catabolism is
mainly detoxified through amination of glutamate to glutamine by
the enzyme glutamine synthetase. This enzyme is exclusively
Figure 4. Effects of GA and 3-OHGA on oligodendrocytes. (Left panel) Immunohistochemical staining for galactocerebroside (GalC, DIV 8) and
myelin basic protein (MBP, DIV 14) on cryosections derived from protocol A (DIV 8) and protocol B (DIV 14). Oligodendrocytes are indicated by black
arrows. Scale bar: 100 mm. (Right panel) Representative western blots with data quantification of whole-cell lysates for MBP for protocol B (DIV 14).
Actin was used as a loading control. The quantifications of MBP levels are expressed as percentage of respective controls. The values represent the
mean 6 SD from 3 replicates taken from 2 independent experiments.
doi:10.1371/journal.pone.0053735.g004
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Figure 5. Effects of GA and 3-OHGA on biochemical parameters measured in culture medium. Glucose (A), lactate (B), ammonium (C) and
glutamine (D) were measured in the medium of cultures treated with protocols A (DIV 8) or B (DIV 14). Mean 6 SD of 7 replicate cultures assessed by
Student’s t-test; *p,0.05, **p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0053735.g005
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Figure 6. Evaluation of cell death after treatment with GA and 3-OHGA. (A; left panel) Immunohistochemical staining for cleaved caspase-3
(red signal). Scale bar: 100 mm. (A; right panel) Representative western blots with data quantification of whole-cell lysates for full length caspase-3
and the large fragment of cleaved (e.g. activated) caspase-3 for protocol A (DIV 8, above) and protocol B (DIV 14, below). Actin was used as a loading
control. The quantifications of cleaved caspase-3 are expressed as percentage of respective controls. The values represent the mean 6 SEM from 3
replicates taken from 2 independent experiments. (B) In situ cell death assay with TUNEL (green signal) and cleaved caspase-3 (red signal) on DIV 8
(protocol A). Merge of both signals leads to double-stained cells appearing in yellow. Scale bar: 100 mm. (C) LDH in culture medium of cultures from
protocol A (DIV 8, above) and protocol B (DIV 14, below). Mean 6 SD of 7 replicate cultures assessed by Student’s t-test; **p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0053735.g006
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expressed in astrocytes. In previous studies we have shown that
ammonium concentrations up to 5 mM are not toxic for
astrocytes, but induce cell death in neurons and oligodendrocytes
[18]. Thus, we can conclude that the 3-OHGA-induced primary
astrocytic death is not related to high ammonium levels, but might
be secondarily followed by neuronal and oligodendrocytic death
triggered by ammonium accumulation. This hypothesis is
supported by the observation of neuronal loss in the Gcdh2/2
mouse model [13].
Analysis of media from treated and control cultures on DIV 14
showed a marked increase in lactate with concomitant decrease in
glucose concentrations. This combination can be observed in
plasma of children with GA-I during acute encephalopathic crises.
Underlying mechanisms may be the inhibition of the TCA cycle
and/or respiratory chain with shift to lactate at the end of
glycolysis, which is also supported by the 2-fold increase of the
lactate/pyruvate ratio observed under 3-OHGA exposure. Lamp
et al. have shown that 3-OHGA and GA inhibit astrocytic efflux
and neuronal uptake of TCA cycle intermediates. These results
suggest that elevated levels of 3-OHGA and GA may lead to
neuronal injury and cell death via disruption of TCA cycle activity
[21]. Direct effects on the respiratory chain have been reported
controversially: While a recent report failed to prove changes on
the activity of the different respiratory chain complexes in the
Gcdh2/2 mouse during metabolic crisis [22], other publications
confirmed an impact of GA and/or 3-OHGA on the mitochon-
drial energy metabolism [23,24]. TCA and respiratory chain
dysfunction is also assumed by the ‘‘toxic metabolite’’ hypothesis
that postulates an interference of these organic acids with
mitochondrial energy metabolism [23]. This is consistent with
the finding of mainly non-apoptotic (likely necrotic) cell death,
which has been shown to be prevalent in animal models of
mitochondrial dysfunction [25] as well as in neuropathology of
humans with Leigh syndrome [26].
Our previous results on ammonium toxicity combined with the
new results on our GA-I in vitro model suggest the following three-
step model for brain damage in GA-I: (i) 3-OHGA (and GA) cause
via a so far unknown mechanism massive cell death of astrocytes;
(ii) loss of the astrocytic subpopulation results in deficiency of
glutamine synthetase activity leading to ammonium accumulation;
and (iii) ammonium accumulation results in secondary death of
other brain cells (neurons and oligodendrocytes).
Conclusions
In an in vitro brain cell culture model for GA-I, we confirm the
toxicity of the two main accumulating metabolites, GA and 3-
OHGA, on brain cells; the latter being the most deleterious
substance. Our data allow the following conclusions: (i) 3-OHGA
leads to massive cell death most likely of non-apoptotic origin; (ii)
among the different cellular subpopulations in our model,
astrocytes appeared to be the most vulnerable cells; (iii)
ammonium accumulation might be secondary to the loss of the
astrocytic enzyme glutamine synthetase and play a role in GA-I-
related brain damage; (iv) indirect signs of impaired energy
metabolism seem to support previous studies suggesting partici-
pation of this mechanism in the neuropathogenesis of GA-I. We
suggest a three-step model for brain damage in GA-I. This model,
if confirmed in vivo, may explain why investigation of direct
neurotoxicity of GA and 3-OHGA has been difficult so far. It may
open new therapeutic approaches for neuroprotection focused on
the inhibition/detoxification of intracerebrally-produced ammo-
nium. We might thus be one step closer to the prevention of the
destructive processes that cause permanent handicap in GA-I.
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Figure 7. Expression of GCDH in neurons, astrocytes and
oligodendrocytes. In situ hybridization for GCDH mRNA in adult rat
brain (16 mm cryosections), co-labeled by immunohistochemistry for
specific markers of neurons (NeuN), astrocytes (GFAP) or oligoden-
drocytes (MBP). Top and central panels show expression of GCDHmRNA
(blue signal) in cortical neurons (top; NeuN, red signal), while GCDH
mRNA could not be detected in cortical astrocytes (central; GFAP, red
signal, arrows pointing at astrocytic cell bodies). Bottom panel shows
GCDH mRNA (blue signal) in granular neurons of cerebellum, while
GCDH mRNA appears absent from adjacent oligodendrocytes in white
matter of cerebellum (bottom; MBP, red signal). Scale bar: 100 mm.
doi:10.1371/journal.pone.0053735.g007
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